Search
Vor Biopharma Inc
VORAdd to Watchlist
19.420USD
+0.100+0.52%
Close 11-13 16:00（ET）
1.19BMarket Cap
LossP/E TTM
Vor Biopharma Inc (VOR) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Vor Biopharma Inc in the past month.
Buy
4 Strong Buy
4 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
39.000USD+98.17%
VOR Analyst Recommendation Trends
In the current month, VOR has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. VOR average Analyst price target in the last month is 39.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
3
4
4
4
4
4
4
4
3
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
9
9
9
9
7
Financial Forecasting
Based on analysts' estimates, VOR EPS is projected to reach -0.940 in FY2026Q4, following reported EPS of -1.453 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.78
-0.70
-0.82
-0.94
-1.07
Actual
-5.11
-1.16
-1.45
--
--
Surprise
-554.15%
-64.24%
-76.22%
--
--
FAQs
What is Vor Biopharma Inc's price target?
Analysts forecast that Vor Biopharma Inc's price target is USD 57.50, with the highest forecast at USD 64.00 and the lowest forecast at USD 8.00.
How have Vor Biopharma IncVOR's recent earnings per share performed?
The market expectation was USD -1.45, while Vor Biopharma IncVOR's earnings per share (EPS) for the previous quarter was USD -1.16. EPS for the next quarter is expected at USD -0.94.
What is the analyst rating for Vor Biopharma Inc?
Based on the ratings of Vor Biopharma Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.